| Application no. and date | 15885769.8 (espacenet) (Federated) (European Patent Register), 20151212 | | Patent/reg. no. and date | DK/EP 3229827, 20190904 | | Publication date | 20171018 | | Priority no. and date | US 201462091379 P, 20141212 | | EP pub. no. and date |
EP 3229827 20171018 | | Effective date | | | Applicant/owner | ImmuPharma France SA, 5 rue du Rhône
68100 Mulhouse, FR,
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, 3, Rue Michel-Ange
75794 Paris, FR | | Applicant ref. no. | V151770 | | Inventor | MULLER, Sylviane, 4 Quai Rouget de l'Isle
67000 Strasbourg, FR,
BRIAND, Jean-Paul, 4 Quai Rouget de l'Isle
67000 Strasbourg, FR,
ZIMMER, Robert H., 5 Rue du Rhône
68100 Mulhouse, FR | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 37/00 (2006.01) | | Title | MODIFICEREDE PEPTIDER OG ANVENDELSE DERAF TIL BEHANDLING AF KRONISKE
INFLAMMATORISKE SYGDOMME | | Int. application no. | EP2015079395 | | Int. publication no. | WO2016192819 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
